Evommune EVMN Accounts payable and other current liabilities
Accounts payable and other current liabilities at other companies
Other financials
Where this comes from
Reported directly by Evommune in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.
The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evommune 's accounts payable and other current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Evommune 's accounts payable and other current liabilities?
- Evommune (EVMN) reported accounts payable and other current liabilities of $91.42K in Q1 2026.
- How has Evommune 's accounts payable and other current liabilities changed year-over-year?
- Evommune 's accounts payable and other current liabilities increased by 5.1% year-over-year, from $86.96K to $91.42K.
- What does accounts payable and other current liabilities mean?
- Tracks the net change in obligations to suppliers and service providers for goods and services received but not yet paid for. An increase in this balance serves as a source of operating cash flow by delaying cash outflows. It is a key indicator of the company's short-term liability management and vendor payment terms.